The choice of local destruction method of colorectal cancer liver metastases

colorectal cancer, metastases, liver, surgical treatment, thermal destruction, cryodestruction, radiofrequency ablation, survival, complications

1. Cutsem E.V., Cervantes A., Adam R., Sobrero A., Van Krieken J.H., Aderka D., Aguilar E.A., Bardelli A., Benson A., Bodoky G., Ciardiello F., D’Hoore A., Diaz-Rubio E., Douillard J.-Y., Ducreux M., Falcone A., Grothey A., Gruenberger T., Haustermans K., Heinemann V., Hoff P., Köhne C.-H., Labianca R., Laurent-Puig P., Ma B., Maughan T., Muro K., Normanno N., sterlund P., Oyen W.J.G., Papamichael D., Pentheroudakis G., Pfeiffer P., Price T.J., Punt C., Ricke J., Roth A., Salazar R., Scheithauer W., Schmoll H.J., Tabernero J., Taïeb J., Tejpar S., Wasan H., Yoshino T., Zaanan A., Arnold D. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 2016; 27 (8): 1386–142. https://doi.org/10.1093/annonc/mdw235

2. Sorich M.J., Wiese M.D., Rowland A., Kichenadasse G., McKinnon R.A., Karapetis C.S. Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a metaanalysis of randomized, controlled trials. Ann. Oncol. 2015; 26 (1): 13–21. https://doi.org/0.1093/annonc/mdu378

3. Pietrantonio F., Petrelli F., Coinu A., Di Bartolomeo M., Borgonovo K., Maggi C., Cabiddu M., Iacovelli R., Bossi I., Lonati V., Ghilardi M., de Braud F., Barni S. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. Eur. J. Cancer. 2015; 51 (5): 587–594. https://doi.org/10.1016/j.ejca.2015.01.054

4. Weiser M.R., Jarnagin W.R., Saltz L.B. Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach? Oncology (WillistonPark). 2013; 27 (11): 1074–1078.

5. Adam R., De Gramont A., Figueras J., Guthrie A., Kokudo N., Kunstlinger F., Loyer E., Poston G., Rougier P., RubbiaBrandt L., Sobrero A., Tabernero J., Teh C., Van Cutsem E. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012; 17 (10): 1225–1239. https://doi.org/10.1634/theoncologist.2012-0121

6. Nordlinger B., Sorbye H., Glimelius B., Poston G.J., Schlag P.M., Rougier P., Bechstein W.O., Primrose J.N., Walpole E.T., Finch-Jones M., Jaeck D., Mirza D., Parks R.W., Mauer M., Tanis E., Van Cutsem E., Scheithauer W., Gruenberger T. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013; 14 (12): 1208–1215. https://doi.org/10.1016/S1470-2045(13)70447-9

7. Nordlinger B., Sorbye H., Glimelius B., Poston G.J., Schlag P.M., Rougier P., Bechstein W.O., Primrose J.N., Walpole E.T., Finch-Jones M., Jaeck D., Mirza D., Parks R.W., Collette L., Praet M., Bethe U., Van Cutsem E., Scheithauer W., Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008; 371 (9617): 1007–1016. https://doi.org/10.1016/S0140-6736(08)60455-9

8. Primrose J., Falk S., Finch-Jones M., Valle J., O'Reilly D., Siriwardena A., Hornbuckle J., Peterson M., Rees M., Iveson T., Hickish T., Butler R., Stanton L., Dixon E., Little L., Bowers M., Pugh S., Garden O.J., Cunningham D., Maughan T., Bridgewater J. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol. 2014; 15 (6): 601–611. https://doi.org/10.1016/S1470-2045(14)70105-6

9. Al’perovich B.I. Istoricheskiy ocherk kriokhirurgii v Rossii. Kriokhirurgiya v gepatologii. Dostizheniya kriomeditsiny [Historical background of cryosurgery in Russia. Cryosurgery in hepatology. Cryomedicine achievements]. Saint Petersburg: Nauka, 2001. P. 4–21. (In Russian)

10. Kriokhirurgicheskie operatsii pri zabolevaniyakh pecheni i podzheludochnoy zhelezy [Сryosurgical procedures for diseases of the liver and pancreas]. Al’perovich B.I., ed. Moscow: GEOTAR-Med; 2015. 264 p. (In Russian)

11. Vishnevskiy V.A., Gavrilin A.V., Sergeeva O.N., Ionkin D.A. Radiofrequency ablation in treatment of focal liver lesions. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2004; 9 (2): 77–79. (In Russian)

12. Vishnevskiy V.A., Ionkin D.A., Gavrilin A.V., Efanov M.G., Zhavoronkova O.I. Radio-frequency thermoablation of liver malignant neoplasms. Moskovskiy khirurgicheskiy zhurnal = Moscow Surgical Journal. 2008; 3 (3): 28–37. (In Russian)

13. Van Cutsem E., Cervantes A., Nordlinger B., Arnold D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2014; 25 (Suppl 3): iii1–iii9. https://doi.org/10.1093/annonc/mdu260

14. Ruers T., Punt C., Van Coevorden F., Pierie J.P., BorelRinkes I., Ledermann J.A., Poston G., Bechstein W., Lentz M.A., Mauer M., Van Cutsem E., Lutz M.P., Nordlinger B. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): longterm survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). J. Clin. Oncol. 2015; 33 (15 Suppl): abstr 3501.

15. Kosyrev V.Y., Dolgushin B.I. Peculiarity of radio-frequency thermoablation procedure for liver cancer. review. Medicinskaya vizualizaciya = Medical visualization. 2011; 2 (2): 13–18. (In Russian)

16. Zhao A.V., Ionkin D.A. Primenenie kriodestrukcii pri pervichnom i metastaticheskom rake pecheni [The use of cryodestruction in primary and metastatic liver cancer]. In Revishvili A.Sh., Zhao A.V., Ionkin D.A., eds. Cryosurgery. Moscow: GEOTAR-Med, 2019. P. 198–220. (In Russian)

17. Schmoll H.J., Van Cutsem E., Stein A., Valentini V., Glimelius B., Haustermans K., Nordlinger B., van de Velde C.J., Balmana J., Regula J., Nagtegaal I.D., Beets-Tan R.G., Arnold D., Ciardiello F., Hoff P., Kerr D., Köhne C.H., Labianca R., Price T., Scheithauer W., Sobrero A., Tabernero J., Aderka D., Barroso S., Bodoky G., Douillard J.Y., El Ghazaly H., Gallardo J., Garin A., Glynne-Jones R., Jordan K., Meshcheryakov A., Papamichail D., Pfeiffer P., Souglakos I., Turhal S., Cervantes A. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann. Oncol. 2012; 23 (10): 2479–2516. https://doi.org/10.1093/annonc/mds236